1. Home
  2. OCC vs ANIX Comparison

OCC vs ANIX Comparison

Compare OCC & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Optical Cable Corporation

OCC

Optical Cable Corporation

HOLD

Current Price

$16.92

Market Cap

130.0M

Sector

Industrials

ML Signal

HOLD

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

HOLD

Current Price

$3.56

Market Cap

108.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OCC
ANIX
Founded
1983
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
130.0M
108.5M
IPO Year
2001
2013

Fundamental Metrics

Financial Performance
Metric
OCC
ANIX
Price
$16.92
$3.56
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$8.67
AVG Volume (30 Days)
380.2K
282.9K
Earning Date
06-04-2026
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
290.91
12.82
EPS
N/A
N/A
Revenue
$87,828,590.00
$210,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
37.03
N/A
52 Week Low
$4.02
$2.32
52 Week High
$27.98
$5.46

Technical Indicators

Market Signals
Indicator
OCC
ANIX
Relative Strength Index (RSI) 51.54 65.77
Support Level $4.80 $2.48
Resistance Level $27.98 $4.52
Average True Range (ATR) 1.58 0.28
MACD -0.22 0.04
Stochastic Oscillator 49.02 85.86

Price Performance

Historical Comparison
OCC
ANIX

About OCC Optical Cable Corporation

Optical Cable Corp manufactures a broad range of fiber optic and copper data communication cabling and connectivity solutions for the enterprise, wireless carrier, and specialty markets. The Company offers high quality products that operate as a system solution or integrate with other components, including fiber, copper, hybrid cabling, cabinets, racks, enclosures, and deployable solutions for enterprise networks, data centers, residential, campus, Passive Optical LAN installations, and customized applications in military, industrial, mining, petrochemical, renewable energy, and broadcast industries. It operates a single reportable segment covering the design, development, manufacture, and marketing of its cabling and connectivity solutions.

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.

Share on Social Networks: